Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.
Hsiung GY, Alipour S, Jacova C, Grand J, Gauthier S, Black SE, Bouchard RW, Kertesz A, Loy-English I, Hogan DB, Rockwood K, Feldman HH. Hsiung GY, et al. Among authors: loy english i. Dement Geriatr Cogn Disord. 2008;25(6):483-90. doi: 10.1159/000126499. Epub 2008 Apr 16. Dement Geriatr Cogn Disord. 2008. PMID: 18417973
An exploration of cognitive subgroups in Alzheimer's disease.
Davidson JE, Irizarry MC, Bray BC, Wetten S, Galwey N, Gibson R, Borrie M, Delisle R, Feldman HH, Hsiung GY, Fornazzari L, Gauthier S, Guzman D, Loy-English I, Keren R, Kertesz A, George-Hyslop PS, Wherrett J, Monsch AU. Davidson JE, et al. Among authors: loy english i. J Int Neuropsychol Soc. 2010 Mar;16(2):233-43. doi: 10.1017/S1355617709991160. Epub 2009 Dec 4. J Int Neuropsychol Soc. 2010. PMID: 19958568 Free PMC article.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.
Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, Hollingworth P, Hsiung GY, Johnson J, Kelly DD, Keren R, Kertesz A, King KS, Lovestone S, Loy-English I, Matthews PM, Owen MJ, Plumpton M, Pryse-Phillips W, Prinjha RK, Richardson JC, Saunders A, Slater AJ, St George-Hyslop PH, Stinnett SW, Swartz JE, Taylor RL, Wherrett J, Williams J, Yarnall DP, Gibson RA, Irizarry MC, Middleton LT, Roses AD. Li H, et al. Among authors: loy english i. Arch Neurol. 2008 Jan;65(1):45-53. doi: 10.1001/archneurol.2007.3. Epub 2007 Nov 12. Arch Neurol. 2008. PMID: 17998437
Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.
Inkster B, Rao AW, Ridler K, Filippini N, Whitcher B, Nichols TE, Wetten S, Gibson RA, Borrie M, Kertesz A, Guzman DA, Loy-English I, Williams J, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM. Inkster B, et al. Among authors: loy english i. Neurobiol Aging. 2012 Mar;33(3):457-65. doi: 10.1016/j.neurobiolaging.2010.04.018. Epub 2010 Jun 8. Neurobiol Aging. 2012. PMID: 20570408
Gender differences in dementia risk factors.
Azad NA, Al Bugami M, Loy-English I. Azad NA, et al. Among authors: loy english i. Gend Med. 2007 Jun;4(2):120-9. doi: 10.1016/s1550-8579(07)80026-x. Gend Med. 2007. PMID: 17707846 Review.
14 results